310.545—Drug products containing certain active ingredients offered over-the-counter (OTC) for certain uses.
(a)
A number of active ingredients have been present in OTC drug products for various uses, as described below. However, based on evidence currently available, there are inadequate data to establish general recognition of the safety and effectiveness of these ingredients for the specified uses:
(1) Topical acne drug products.
(2) Anticaries drug products—
(i) Approved as of May 7, 1991.
(ii) Approved as of October 7, 1996.
(3) Antidiarrheal drug products—
(i) Approved as of May 7, 1991.
(ii)
Approved as of April 19, 2004; April 18, 2005, for products with annual sales less than $25,000.
(4) Antiperspirant drug products—
(i) Ingredients—
Approved as of May 7, 1991.
(ii) Approved as of December 9, 2004; June 9, 2005, for products with annual sales less than $25,000.
(6) Cold, cough, allergy, bronchodilator, and antiasthmatic drug products—
(i) Antihistamine drug products—
(ii) Nasal decongestant drug products—
(A) Approved as of May 7, 1991.
(B) Approved as of August 23, 1995.
(C)
Approved as of April 11, 2007; October 11, 2007, for products with annual sales less than $25,000. Any ingredient(s) labeled with claims or directions for use for sinusitis or for relief of nasal congestion associated with sinusitis.
(iii) Expectorant drug products.
(iv) Bronchodilator drug products—
(A) Approved as of October 2, 1987.
(B)
Approved as of January 29, 1996. Any combination drug product containing theophylline (e.g., theophylline and ephedrine, or theophylline and ephedrine and phenobarbital).
(C)
Approved as of June 19, 1996. Any ingredient(s) in a pressurized metered-dose inhaler container.
(D)
Approved as of October 29, 2001. Any oral bronchodilator active ingredient (e.g., ephedrine, ephedrine hydrochloride, ephedrine sulfate, racephedrine hydrochloride, or any other ephedrine salt) in combination with any analgesic(s) or analgesic-antipyretic(s), anticholinergic, antihistamine, oral antitussive, or stimulant active ingredient.
(7) Dandruff/seborrheic dermatitis/psoriasis drug products.
(8) Digestive aid drug products—
(i) Approved as of May 7, 1991.
(ii) Approved as of November 10, 1993.
(iii)
Charcoal, activated
(10) External analgesic drug products—
(i) Analgesic and anesthetic drug products.
(ii) Counterirritant drug products.
(iii) Male genital desensitizer drug products.
(iv) Diaper rash drug products.
Any ingredient(s) labeled with claims or directions for use in the treatment and/or prevention of diaper rash.
(v) Fever blister and cold sore treatment drug products.
(vi) Insect bite and sting drug products.
(vii) Poison ivy, poison oak, and poison sumac drug products.
(12) Laxative drug products—
(i)
(i)
(B) Bulk laxatives—
Approved as of March 29, 2007.
(iv)
(A) Stimulant laxatives—Approved as of May 7, 1991.
(iv)
(B) Stimulant laxatives—Approved as of January 29, 1999.
(C) Stimulant laxatives—
Approved as of November 5, 2002.
(14) Oral health care drug products (nonantimicrobial).
(15) Topical otic drug products—
(i) For the prevention of swimmer's ear and for the drying of water-clogged ears, approved as of May 7, 1991.
(ii) For the prevention of swimmer's ear, approved as of August 15, 1995.
(16) Poison treatment drug products.
(17) Skin bleaching drug products.
(18) Skin protectant drug products—
(i)
(B)
Ingredients—Approved as of June 4, 2004; June 6, 2005, for products with annual sales less than $25,000.
(ii) Astringent drug products.
(iii) Diaper rash drug products.
(iv) Fever blister and cold sore treatment drug products.
(v) Insect bite and sting drug products—
(A) Ingredients—Approved as of November 10, 1993.
(B)
Ingredients—Approved as of June 4, 2004; June 6, 2005, for products with annual sales less than $25,000.
(vi) Poison ivy, poison oak, and poison sumac drug products—
(A) Ingredients—Approved as of November 10, 1993.
(B)
Ingredients—Approved as of June 4, 2004; June 6, 2005, for products with annual sales less than $25,000.
(20) Weight control drug products.
(21) Ophthalmic drug products.
(i) Ophthalmic anesthetic drug products.
(ii) Ophthalmic anti-infective drug products.
(iii) Ophthalmic astringent drug products.
(iv) Ophthalmic demulcent drug products.
(v) Ophthalmic vasoconstrictor drug products.
(22) Topical antifungal drug products.
(i) Diaper rash drug products.
Any ingredient(s) labeled with claims or directions for use in the treatment and/or prevention of diaper rash.
(iii)
Any ingredient(s) labeled with claims or directions for use on the scalp or on the nails.
(23) Internal analgesic drug products—
(i) Approved as of November 10, 1993.
(ii)
Approved as of February 22, 1999.
(24) Orally administered menstrual drug products—
(i) Approved as of November 10, 1993.
(ii)
Approved as of February 22, 1999.
(25) Pediculicide drug products—
(i) Approved as of November 10, 1993.
(ii) Approved as of June 14, 1994.
The combination of pyrethrum extract (formerly named pyrethrins) and piperonyl butoxide in an aerosol dosage formulation.
(26) Anorectal drug products—
(i) Anticholinergic drug products.
(ii) Antiseptic drug products.
(iii) Astringent drug products.
(iv) Counterirritant drug products.
(v) Keratolytic drug products.
(vi) Local anesthetic drug products.
(vii) Other drug products.